Navigation Links
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
Date:6/28/2008

MOUNTAIN VIEW, Calif., June 28 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today presented data from an in-vitro study evaluating receptor pharmacology of MAP0004, orally inhaled dihydroergotamine (DHE) for the potential treatment of migraine, compared to intravenous (IV) DHE. The study results were among six posters relating to the MAP0004 program that the Company presented at the American Headache Society 50th Annual Scientific Meeting in Boston, MA.

In this receptor pharmacology study, MAP0004 stimulated receptors that relieve migraine at levels comparable to IV DHE, but did not activate receptors associated with side effects frequently seen with IV DHE. In addition, MAP0004 did not affect receptors that have a role in regulating pulmonary function.

"The selective binding of MAP0004 at receptors associated with migraine rather than those associated with side effects offers a mechanistic hypothesis for the favorable safety and efficacy profile of MAP0004 compared to IV DHE that we have observed in our initial clinical studies," said Thomas A. Armer, Ph.D., Chief Scientific Officer of MAP Pharmaceuticals. "The absence of negative effects of MAP0004 on pulmonary function in asthmatic subjects observed in a Phase 2 study is also important because migraine and asthma are frequently co-morbid conditions."

MAP0004 is designed to be self-administered by patients at home via MAP Pharmaceuticals' proprietary Tempo(R) inhaler. In Phase 2 studies with migraneurs and with asthmatics, treatment with MAP0004 was well-tolerated, with no serious adverse events reported. Drug-induced nausea was very low and migraine-associated nausea also decreased with treatment.

The Company presented a poster summariz
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
2. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
3. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
4. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
5. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
6. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
7. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
8. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
9. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
10. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
11. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... COLORADO SPRINGS, Colo. , July 29, 2014 /PRNewswire-USNewswire/ ... remote-controlled catheter (MARC) which could allow physicians to see ... stroke may hold promise, according to study authors who ... Surgery (SNIS) 11 th Annual Meeting in ... findings stand to advance the field of neurointervention, a ...
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
(Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... June 15, 2011 The American Academy of ... 2011 AAFP Foundation Pfizer Immunization Award winners. These ... achieved increased immunization rates in their communities through ... the AAFP,s National Conference were presented to 16 ...
... June 15, 2011 To address surgeons, need for ... in open surgery, Ethicon Endo-Surgery, Inc. (EES) today announces ... advanced bipolar technology.  The new technology is designed with ... sealing vessels consistently along the length of the 40mm ...
Cached Medicine Technology:Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 2Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 3Ethicon Endo-Surgery Launches ENSEAL® G2 Super Jaw 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 truBrain has ... fix provided by energy drinks. Think Drinks , ... nutrition that creates optimal conditions for memory, complex reasoning ... truBrain hopes to raise $50,000 over the course of ... stable mental boost and have compounding effects over time ...
(Date:7/29/2014)... 2014 The report “Filling Equipment ... (Rotary, Volumetric, Aseptic, Net Weight), Process (Manual, Semi-Automatic, ... Global Trend & Forecast to 2019”, defines the ... beverage, pharmaceutical, and cosmetic segments with analyses and ... these segments, in terms of value. It also ...
(Date:7/29/2014)... 2014 CD-adapco™, the largest privately ... software, today announced its renewed membership with ... public-private partnership focused exclusively on the unique needs ... progress in the first year by bringing together ... Computational Modeling and Simulation (CM&S). This momentum will ...
(Date:7/29/2014)... Outsourced coding and Clinical Documentation Improvement ... of hospitals contracting for external CDI services help ... the recently published Black Book™ survey of 650 ... reports “Top Ranked Clinical Documentation Improvement Vendors”. , ... audit, review and programming. By Q3 2015, 71 ...
(Date:7/29/2014)... Botanica Day Spa continues their celebration of summer with the ... waxes to clients in the Tampa Bay area. In ... a number of new client specials including great deals on ... a free mini facial with their first Brazilian wax at ... downtown Clearwater, FL celebrates its twentieth year in business in ...
Breaking Medicine News(10 mins):Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:CD-adapco Helps Advance the Use of Simulation in Medical Device Industry 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3Health News:Award-Winning Botanica Day Spa Celebrates 12,000 Brazilian Bikini Waxes 2Health News:Award-Winning Botanica Day Spa Celebrates 12,000 Brazilian Bikini Waxes 3
... magazines or advertising for,treatment information, NEW YORK, ... ( http://www.injectablesafety.org ) and the health and,beauty community ... joint survey reporting that 40% of consumers are ... of consumers feel FDA approval,of an injectable is ...
... for Dedication to Improving, Animal Health and Well-Being; Co-sponsored ... FANCY, CAT FANCY and Veterinary ... you think your veterinarian is the,best in America, nominate ... Vet,for a Healthy Pet(SM) Contest. The national short-essay contest ...
... Mercury Computer,Systems, Inc. (NASDAQ: MRCY ), ... complex image, sensor, and signal,processing applications, announced that ... on Thursday, May 29, 2008 at the Cowen ... at the New York Palace Hotel, in New ...
... a health care problem all over the world, with 130 ... and has variable results according to the genotype of the ... virus clearance at the end of the treatment called End ... ETR have a relapse within the next six months. Thus, ...
... advance underdeveloped approaches to designing a preventive HIV vaccine, ... part of the National Institutes of Health, is launching ... cells, immune cells that can produce antibodies with the ... will strengthen and expand the scientific foundation of HIV ...
... use yields practical guides for,physicians, consumers, employers, health ... The non-profit eHealth,Initiative (eHI) and the Center ... of a widely anticipated report detailing the,impact of ... plans and policy makers nationwide. Based on,research as ...
Cached Medicine News:Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 2Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 3Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 4Health News:Morris Animal Foundation Searches for America's Best Vet With 'Thank Your Vet for a Healthy Pet(SM)' Contest 2Health News:Morris Animal Foundation Searches for America's Best Vet With 'Thank Your Vet for a Healthy Pet(SM)' Contest 3Health News:Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008 2Health News:NIAID to advance B-cell approach to HIV vaccines 2Health News:NIAID to advance B-cell approach to HIV vaccines 3Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 2Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 3
Can download data from your A&D balance directly to your PC saving time and reducing the chances of manually recording the wrong weighing data; 60 month warranty; automatic adjustable environment set...
... The ABI Prism 7000 Sequence Detection ... system that detects and quantitates nulceic ... detection of accumulated PCR product is ... fluorescence detection, and application-specific software in ...
... 3100 system offers continuous, unattended operation ... separation and detection, and data analysis. ... and importing sample information, the operator ... Run command. The instrument requires no ...
Coated-Tube (CT) RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum...
Medicine Products: